Literature DB >> 26142228

[Sinus thrombosis and idiopathic intracerebral hypertension: Thrombophilia and hormonal influence as potentially relevant causal connections].

Rainer B Zotz1.   

Abstract

BACKGROUND: Cerebral venous sinus thrombosis and idiopathic intracerebral hypertension (IIH) can lead to impaired vision, which is why the suspected diagnosis is often initially made by an ophthalmologist. PROBLEM AND AIMS: This study aimed at discovering common features between the two underlying conditions and provide ophthalmologists with concrete measures for differential diagnosis and for the management of affected patients based on these similarities.
MATERIAL AND METHODS: This article presents detailed profiles of the underlying conditions and compares the two, focusing on similarities with respect to risk factors.
RESULTS: The following common risk factor profiles of the two underlying conditions could be determined: (1) women before menopause, (2) administration of female hormones and (3) thrombophilia. DISCUSSION: Based on these findings at least a partial overlap of both pathophysiologies is suspected. In particular, undiagnosed cerebral thrombosis or microthrombosis can cause IIH. This mechanism could explain the typical thrombophilic risk profile of IIH, which is analogous to that of cerebral venous sinus thrombosis, including the well-established interaction of estrogens and thrombophilic risk factors.

Entities:  

Keywords:  Cerebral venous sinus thrombosis; Differential diagnosis; Ophthalmologist; Pathophysiology; Vision disorders

Mesh:

Substances:

Year:  2015        PMID: 26142228     DOI: 10.1007/s00347-015-0061-3

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  25 in total

Review 1.  Cerebral venous thrombosis.

Authors:  Gregory Piazza
Journal:  Circulation       Date:  2012-04-03       Impact factor: 29.690

Review 2.  Cerebral venous thrombosis: an update.

Authors:  Marie-Germaine Bousser; José M Ferro
Journal:  Lancet Neurol       Date:  2007-02       Impact factor: 44.182

3.  Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions.

Authors:  R M Ahmed; M Wilkinson; G D Parker; M J Thurtell; J Macdonald; P J McCluskey; R Allan; V Dunne; M Hanlon; B K Owler; G M Halmagyi
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-28       Impact factor: 3.825

4.  Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children.

Authors:  Roberto De Simone; Angelo Ranieri; Silvana Montella; Deborah I Friedman; Grant T Liu; Kathleen B Digre
Journal:  Neurology       Date:  2014-03-18       Impact factor: 9.910

5.  Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis.

Authors:  Ida Martinelli; Paolo Bucciarelli; Serena M Passamonti; Tullia Battaglioli; Emanuele Previtali; Pier Mannuccio Mannucci
Journal:  Circulation       Date:  2010-06-14       Impact factor: 29.690

6.  Heparin treatment in sinus venous thrombosis.

Authors:  K M Einhäupl; A Villringer; W Meister; S Mehraein; C Garner; M Pellkofer; R L Haberl; H W Pfister; P Schmiedek
Journal:  Lancet       Date:  1991-09-07       Impact factor: 79.321

7.  Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis.

Authors:  S F de Bruijn; J Stam
Journal:  Stroke       Date:  1999-03       Impact factor: 7.914

Review 8.  Thrombolytics for cerebral sinus thrombosis: a systematic review.

Authors:  Patricia Canhão; Filipa Falcão; José M Ferro
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

9.  Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children.

Authors:  Deborah I Friedman; Grant T Liu; Kathleen B Digre
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

Review 10.  Anticoagulation for cerebral sinus thrombosis.

Authors:  J Stam; S F De Bruijn; G DeVeber
Journal:  Cochrane Database Syst Rev       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.